MINIMED 670G HYBRID CLOSED LOOP (HCL) IN THE FIELD
|
|
- Bathsheba Riley
- 6 years ago
- Views:
Transcription
1 MINIMED 670G HYBRID CLOSED LOOP (HCL) IN THE FIELD USE AND EXAMPLES Rich Flores, RD Diabet es Clinical Manger Northern Minnesota/ St. Cloud WARNING: Territory Medtronic performed an evaluation of the MiniMed 670G closed loop system and determined that it may not be safe for use in children under the age of 7 because of the way that the system is designed and the daily insulin requirements. Therefore, this device should not be used in anyone under the age of 7 years old. This device should also not be used in patients who require less than a total daily insulin does of 8 units per day because the device requires a minimum of 8 units per day to operate safely. MARCOM NUMBER HERE 2017 Medtronic MiniMed, Inc. All rights reserved. MiniMed, CareLink, Bolus Wizard and Enlite are registered trademarks and SmartGuard is a trademark of Medtronic MiniMed, Inc. use in children under the age of 7 because of the way that the system is designed and the daily insulin requirements. Therefore, t his
2 IMPORTANT SAFETY INFORMATION: MINIMED 670G SYSTEM The Medtronic MiniMed 670G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons, fourteen years of age and older, requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed 670G system includes Smart Guard technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitor sensor glucose values, and can suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values. The system requires a prescription. The Guardian Sensor (3) glucose values are not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. A confirmatory finger stick test via the CONTOUR NEXT LINK 2.4 blood glucose meter is required prior to making adjustments to diabetes therapy. All therapy adjustments should be based on measurements obtained using the CONTOUR NEXT LINK 2.4 blood glucose meter and not on values provided by the Guardian Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on t he CONTOUR NEXT LINK 2.4 blood glucose meter. It is not recommended to calibrate your CGM device or calculate a bolus using a blood glucose meter result t aken from an alt ernat ive site (palm) or from a control solution test. Do not calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise. If a control solution test is out of range, please note that the result may be transmitted to your pump whenin the Always send mode. WARNING: Medt ronic performed an evaluat ion of t he MiniMed 670G syst em and det ermined t hat it may not be safe for use in children under t he age of 7 because of t he way t hat t he syst em is designed and t he daily insulin requirement s. Therefore t his device should not be used in anyone under t he age of 7 years old. This device should also not be used in pat ient s who require less t han a t ot al daily insulin dose of 8 unit s per day because t he device requires a minimum of 8 unit s per day t o operat e safely. Only use rapid acting U100 insulin with this system. Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed 670G system has not been studied in pregnant women. For complete details, including product and important safety information concerning the system and itscomponents, please consult y-information# minimed-670g and t he appropriat e user guide at / download-library
3 IMPORTANT SAFETY INFORMATION: MINIMED 670G SYSTEM WARNING: Do not use the Suspend on low feature to prevent or treat low glucose. Always confirm your sensor glucose reading using your Blood Glucose (BG) meter, and follow the instructions of your healthcare professional to treat low glucose. Using Suspend on low alone to prevent or t reat low glucose may result in prolonged hypoglycemia. WARNING: Do not use Auto Mode for a period of time after giving a manual injection of insulin by syringe or pen. Manual injections are not accounted for in Auto Mode. Therefore, Auto Mode could deliver too much insulin. Too much insulin may cause hypoglycemia. Consult with your healthcare professional for how long you need to wait after a manual injection of insulin before you resume Auto Mode. WARNING: Do not use the Bolus Wizard feature to calculate a bolus for a period of time after giving a manual injection of insulin by syringe or pen. Manual injections are not accounted for in the active insulin amount. Therefore, the Bolus Wizard calculator could prompt you todeliver more insulin than needed. Too much insulin can cause hypoglycemia. Consult with your healthcare professional for how long you need towait after a manual injection of insulin before you can rely on the active insulin calculation of your Bolus Wizard feature. 940M
4 SAFETY INFORMATION The CareLink soft ware syst em is int ended for use as a t ool t o help manage diabet es. The purpose of t his syst em is t o t ake informat ion t ransmitted from insulin pumps, glucose met ers, and cont inuous glucose monit oring syst ems, and t urn it int o CareLink soft ware report s. The reports provide information that can be used to identify trends and track daily activities such as carbohydrates consumed, meal times, insulin delivery, and glucose readings. Warnings This system is intended to be used by a healthcare professional familiar with the management of diabetes. System results are not intended to produce medical advice and should not be relied upon for such purpose. This product should only be used with supported devices as listed in the User Guide. Patients should be advised to monitor their blood glucose levels at least 4 6 t imes a day. Patients should be advised not to make any changes to their treatment without consulting their healthcare professional. Patients should be advised to make treatment decisions based on healthcare professional guidelines and meter BG results, not glucose sensor results Cont raindicat ions This software should not be used with devices not listed in the User Guide. Nor should this product be used for the treatment of medical conditions other than diabetes. For more details, see user-guides.
5 MEDTRONIC OFF-LABEL POLICY The content of today s medical education and training program is limited to the on-label uses of our products You may find our current product labeling online at: y- informat ion Quest ions concerning off- label use of our product s cannot be answered during t he program In accordance with Medtronic policies and procedures, unsolicited questions concerning the off-label use of Medtronic products may only be answered in the following ways: Written response to an unsolicited from an HCP sent to the Office of Medical Affairs (OMA): rs.medicalinformat ion@medt ronic.com Outside of this program and in a non-public manner, an HCP speaker may respond to a question concerning off-label use Outside of this program and in a non-public manner, a representative of the Medtronic OMA, if present, may respond to a question concerning off-label use
6 MINIMED 670G SYSTEM HOW INSULIN PUMPS WORK
7 GOAL OF EVERY INSULIN REGIMEN: Mimic Insulin Delivery of Healt hy Pancreas Theoret ical Represent at ion of t he Insulin Secret ion of a Healt hy Pancreas Insulin Secret ion Breakfast Lunch Dinner Snack 12am 3am 7am 12pm 6pm 9pm Time of Day Rat e and t ime of insulin secret ion varies based on changing glucose levels
8 PUMPS DELIVER INSULIN IN TWO WAYS Pumps Use Basal and Bolus Insulin Delivery Breakfast Lunch Dinner Snack Insulin 12am 3am 7am 12pm 6pm 9pm Time of Day Insulin delivery more closely mimics insulin secret ion of a healt hy pancreas
9 AVERAGE HOURLY BASAL INSULIN BY AGE GROUP age 3-10 age age age >60 Units/Hour Lantus or Levemir :00 AM 3:00 AM 5:00 AM 7:00 AM 9:00 AM 11:00 AM 1:00 PM 3:00 PM 5:00 PM 7:00 PM 9:00 PM 11:00 PM Hour Scheiner G, Boyer BA. Diabetes Res Clin Pract.2005;69: Lantus is a registered trademark of Sanofi aventis Pharmaceuticals, Inc. Levemir is a registered trademark of Novo Nordisk A/S.
10 PUMPS ARE DESIGNED FOR VARIED BASAL RATES Schemat ic of Basal Rat e Needs Over 24 Hours Insulin Infusion Rat e 0.4 U/ hr Basal rat es can be programmed t o increase for dawn phenomenon 0.7 U/ hr 0.6 U/ hr Basal rat es can be decreased 0.4 U/ hr Higher rat e can be programmed if needed aft er dinner 0.6 U/ hr Basal infusion 12a m 2am 4am 6am 8am 10a m 12p m Time of Day 2pm 4pm 6pm 8pm 10p m 12a m Pumps can be programmed t o deliver basal insulin at different rat es throughout the day according to each patient s unique requirements Lenhard MJ, Reeves GD. Arch Intern Med. 2001;161: Reused with permission.
11 BOLUS WIZARD FEATURE AUTOMATICALLY CALCULATES SMART PUMP Pat ient checks BG BG transmits to pump Records in BW Pat ient ent ers carb grams t o be eat en Records in BW Calculat es bolus amount for t he pat ient ISF: 50 mg/ dl/ unit Target :100 mg/ dl ICR: 10 grams/ unit ( ) = 2.0 unit s 6050 (ISF) 10 = 6.0 unit s Subtracts active insulin from Calculat correct ion es insulin Tot al (2.0u Bolus 0.7u) = 1.3unit s 6.0u + 1.3u = 7.3unit s ICR=insulin t o carbohydrat e rat io ISF= insulin sensitivity factor *Do not use the Bolus Wizard to calculate a bolus for a period of time after giving a manual injection by syringe or pen. The Bolus Wizard does not account for manual injections, and could prompt you to deliver more insulin than needed. Too much insulin may cause hypoglycemia. Consult your healthcare professional for further guidance. *Do not use the Bolus Wizard to calculate a bolus for a period of time after giving a manual injection by syringe or pen. The Bolus Wizard does not account for manual injections, and could prompt you to deliver more insulin than needed. Too much insulin may cause hypoglycemia. Consult your healthcare professional for further guidance.
12 MINIMED 670G SYSTEM OVERVIEW
13 MINIMED 670G SYSTEM OVERVIEW UNDERSTANDING THE BASICS Manual Mode: Basal delivery controlled by programed basal rate(s) Aut o Mode: Basal delivery controlled by dosing algorithm that: Delivers basal insulin in micro doses every 5 minutes Adjusts micro dose based on sensor glucose (SG) Auto basal delivery replaces Manual Mode basal rate delivery Targets SG of 120 mg/dl(pre-set in system) Temporary target of 150 mg/dlcan be set for up to 12 hours Food & Correct ion Boluses: Auto Mode requires patient to enter carbs and/or blood glucose readings for food and/or correction boluses use in children under the age of 7 because of the way that the system is designed and the daily insulin requirements. Therefore, t his
14 TWO MODES OF INSULIN DELIVERY WITH VARYING DEGREES OF SAFEGUARD AUTOMATION MiniMed 670G Hybrid Closed Loop Manual Mode St andard Pump Therapy Aut o Mode Hybrid Closed Loop St and-alone or Sensor-Augment ed SmartGuard Automation - Suspend on low - Suspend before low - Resume basal by SG Sensor-Augment ed only SmartGuard Aut omat ion - Regulates basal delivery Auto Basal (by SG) - Safe Basal (fixed rate) WARNING: Do not use the Suspend On Low feature to prevent or treat low glucose. Always confirm your sensor glucose reading using your BG meter, and follow the instruction of your healthcare professional to treat low glucose. Using suspend on low alone to prevent or t reat low glucose may result in prolonged hypoglycemia.
15 MANUAL MODE PROTOCOLS SAME AS STANDARD PUMP / CGM THERAPY Manual Mode wit h or wit hout CGM Pump Standard protocols used to: Calculate init ial pump set t ings Adjust pump settings CGM SmartGuard HCL features: Suspend by Sensor Suspend on low Suspend before low Resume basal by SG Manual Mode Home Screen without CGM Manual Mode Home Screen with CGM use in children under the age of 7 because of the way that the system is designed and the daily insulin requirements. Therefore, t his
16 SUSPEND ON LOW AUTOMATED INSULIN SUSPENSION BY SENSOR GLUCOSE Low limit settings: 50 to 90 mg/dl Suspend on low: Insulin delivery stops IF SG reaches low limit 180 Sensor Glucose Value Insulin Delivery 0 min 30 min 60 min 90 min 120 min Low Limit : 60 mg/ dl In t his example: Low limit is set at 60 mg/ dl, insulin would suspend when SG reached 60 mg/ dl
17 SUSPEND BEFORE LOW AUTOMATED INSULIN SUSPENSION BY SENSOR GLUCOSE Suspend before low: Insulin delivery st ops IF SG is at or within 70 mg/dlof the set low limit AND Predicts SG will be 20 mg/ dlabove low limit or less wit hin 30 minut es Sensor Glucose Value Insulin Delivery 30 min 0 min 30 min 60 min 90 min 120 min 130 mg/ dl 80 mg/ dl 60 mg/ dl In t his example: Low limit is set at 60mg/dL, insulin would suspend when SG reached 130mg/dL AND was predicted to reach 80 mg/dl within 30 minutes Not e: Must choose between Suspend on low and Suspend before low Recommendat ion: Use Suspend before low use in children under the age of 7 because of the way that the system is designed and the daily insulin requirements. Therefore, t his
18 RESUME BASAL AUTOMATED RESUME BY SENSOR GLUCOSE Basal delivery resumes any t ime aft er 30 minut es of being suspended if: SG is 20 m g/dlabove low limit AND predicted to be > 40 mg/dl above the low limit within 30 minutes Sensor Glucose Value Insulin Delivery START 0 min 30 min 60 min 90 min 120 min 130 mg/ dl 80 mg/ dl 60 mg/ dl In t his example: Low limit is set at 60mg/ dl, insulin resumed at 90 min. when SG reached 80mg/dLAND was predicted to reach 100 mg/dlwithin 30 min. Not e: If 2 hr. suspend limit is reached insulin resumes regardless of SG value Once basal resumes, suspend cannot be triggered again for 30 min. use in children under the age of 7 because of the way that the system is designed and the daily insulin requirements. Therefore, t his
19 AUTO MODE AUTO BASAL SAFE BASAL
20 AUTO MODE SETTINGS CLINICIAN VS. ALGORITHM Setting Clinician Algorit hm Aut o Basal Carb Rat io Insulin Sensitivity Factor Act ive Insulin Time Aut o Mode Target s Not e: All manual mode settings should be kept up to date
21 AUTO BASAL DYNAMIC AND ALWAYS ADJUSTING Goal: Adjust basal insulin to address glucose fluctuations; dawn phenomenon, illness, activity, stress, moderate post-meal excursions Increase / decrease as needed to drive SG to 120 mg/ dl t arget Adjustments are Conservative and not intended to correct a large mismatch in carbs or missed bolus Temp Target : A temporary target of 150 mg/ dl can be set from 30 minutes up to 12 hours Key Concept : Auto basal is adjusted by the dosing algorithm Clinician does not fine-tune Auto Basal
22 AUTO BASAL ADJUSTS DOSING AS SG RISES AND FALLS BASAL DOSING IS INDIVIDUALIZED, DYNAMIC AND VARIABLE SG decreases SG increases SG decreases SG increases SG decreases Range mg/ dl Aut o basal increases Aut o basal increases Aut o basal decreases Aut o basal decreases Aut o basal decreases
23 OVERNIGHT AUTO MODE BASAL DELIVERY IS ADJUSTED BASED ON PATIENT S SG AND TARGET SG OF 120MG/DL 4 Nights (12am to 7am) in a single week of one patient Data on file
24 AUTO MODE AUTO BASAL / SAFE BASAL Smart Guard HCL shield displays when in Aut o Mode Aut o Basal (Blue Shield ) Safe Basal (Gray Shield) Adjust s Basal Delivery every 5 minut es Increases / decreases basal dose: Based on SG and recent insulin needs Targets SG of 120mg/dL Adjusts delivery conservatively to minimize lows and highs Fixed Basal Rat e Activates under certain conditions when auto basal is not available (i.e., lost sensor) Not adjusted for SG Based on recent insulin use Can deliver for up to 90 minutes use in children under the age of 7 because of the way that the system is designed and the daily insulin requirements. Therefore, t his
25 SAFE BASAL CONSERVATIVE FIXED BASAL RATE Purpose : Keep pump in Auto Mode and glucose levels safe while system or patient correct s condit ion Rat e: Algorithm determines the rate Safe Basal delivers based on last 2-6 days of insulin delivery Safe Basal delivery not adjusted based on SG Can deliver for up t o 90 minut es If condit ion resolves wit hin 90 minutes Returns to Auto Basal If condition does not resolve in 90 minutes Exit s t o Manual Mode Not e: System can transition between Auto Basal and Safe Basal. Patient will only be notified if they need to take action such as BG required. use in children under the age of 7 because of the way that the system is designed and the daily insulin requirements. Therefore, t his
26 AUTO MODE EXITS WHAT ARE THEY? WHY DO THEY HAPPEN?
27 AUTO MODE EXITS AN EXPECTED OCCURRENCE Occasionally syst em exit s t o Manual Mode Patient should view exits as a learning opportunity When syst em exit s Aut o Mode pat ient should: 1) Check Auto Mode Readiness screen 2) Complete recommended task(s) to return to Auto Mode as soon as possible Not e: Entering a fingerst ick BG is usually all t hat is needed to return to Auto Mode Key Learning: Encourage patient to check the Home Screen for blue shield at bedtime and upon waking use in children under the age of 7 because of the way that the system is designed and the daily insulin requirements. Therefore, t his
28 AUTO MODE EXIT TOP 5 REASONS* Missed calibration (15% of exits) Calibration not performed when required and Safe Basal expired Prolonged high SG (15% of exits) SG 300 mg/dl greater than 1 hour SG 250 mg/dl greater than 3 hours Aut o Mode max delivery t imeout (10% of exit s) Maximum basal delivery exceeds 4 hours and Safe Basal expired Sensor algorit hm under-read (10% of exits) Difference in BG and SG 35% System determines possible sensor issue Aut o Mode min delivery t imeout (9% of exit s) Minimum basal delivery exceeds 2 ½ hours and Safe Basal expired *Data on file use in children under the age of 7 because of the way that the system is designed and the daily insulin requirements. Therefore, t his
29 CARELINK REPORTS FOR 670G MINIMED 670G SYSTEM Assessment & Progress Weekly Review Adherence Logbook Device Set t ings Meal Bolus Wizard
30 3 NEW REPORTS Assessment & Progress Weekly Review Meal Bolus Wizard
31 ASSESSMENT & PROGRESS REPORT
32 ASSESSMENT & PROGRESS REPORT TIME IN RANGE New metric Analyzes t ime spent wit hin glucose range: 50 m g/dl mg/dl mg/dl mg/dl mg/dl GOAL: Increase the percentage of time spent in target ( mg/dl) use in children under the age of 7 because of the way that the system is designed and the daily insulin requirements. Therefore, t his
33 ASSESSMENT & PROGRESS REPORT AUTO MODE EXIT REASONS
34 ASSESSMENT & PROGRESS REPORT STATISTICS
35 WEEKLY REVIEW REPORT
36 WEEKLY REVIEW REPORT Manual Mode Blood Glucose Auto Mode target (120 mg/ dl) Sensor t racing Calibrat ion BG Target range ( mg/ dl)
INSPIRED BY GIVE HIM MORE. The MiniMed 670G system is the world s first insulin delivery system that automatically adapts to your child s needs.
INSPIRED BY GIVE HIM MORE. The MiniMed 670G system is the world s first insulin delivery system that automatically adapts to your child s needs. * NOW APPROVED FOR AGES 7 AND UP. Waterproof to a depth
More informationTHE MINIMED 670G SYSTEM SCHOOL NURSE GUIDE
THE MINIMED 670G SYSTEM SCHOOL NURSE GUIDE Indicated for type 1 patients 14 and over. Prescription required. WARNING: Medtronic performed an evaluation of the MiniMed 670G system and determined that it
More informationINSPIRED BY GIVE HER MORE. The MiniMed 670G system is the world s first insulin delivery system that automatically adapts to your child s needs.
INSPIRED BY GIVE HER MORE. The MiniMed 670G system is the world s first insulin delivery system that automatically adapts to your child s needs. * NOW APPROVED FOR AGES 7 AND UP. MORE TIME HERE TO USING
More informationReport Reference Guide
Report Reference Guide How to use this guide Each type of CareLink report and its components are described in the following sections. Report data used to generate the sample reports was from sample patient
More informationPROTOCOL FOR HYBRID CLOSED LOOP TECHNOLOGY
PROTOCOL FOR HYBRID CLOSED LOOP TECHNOLOGY Situations Requiring Special Consideration and Resource Documents Second Edition MiniMed 67G System Medical Education TABLE OF CONTENTS A PROTOCOL FOR HYBRID
More informationCareLink. software REPORT REFERENCE GUIDE. Management Software for Diabetes
CareLink Management Software for Diabetes software REPORT REFERENCE GUIDE How to use this guide Each type of CareLink report and its components are described in the following sections. Report data used
More informationReport Reference Guide. THERAPY MANAGEMENT SOFTWARE FOR DIABETES CareLink Report Reference Guide 1
Report Reference Guide THERAPY MANAGEMENT SOFTWARE FOR DIABETES CareLink Report Reference Guide 1 How to use this guide Each type of CareLink report and its components are described in the following sections.
More informationPumps & Sensors made easy. OPADA ALZOHAILI MD FACE Endocrinology Assistant Professor Wayne State University
Pumps & Sensors made easy OPADA ALZOHAILI MD FACE Endocrinology Assistant Professor Wayne State University DeFronzo RA. Diabetes. 2009;58:773-795. Ominous Octet Relationship of b-cell Dysfunction and Development
More informationRELEASED. first steps. Icon Icon name What it means
Icon Icon name What it means Connection The connection icon appears green when the Sensor feature is on and your transmitter is successfully communicating with your pump. The connection icon appears gray
More informationUSING THE MINIMED 670G SYSTEM. Instructions for the Experienced MiniMed 630G System User
USING THE MINIMED 670G SYSTEM Instructions for the Experienced MiniMed 630G System User This is a supplemental guide. For complete instructions and safety information, please see your MiniMed 670G System
More informationUSING THE MINIMED 670G SYSTEM
USING THE MINIMED 670G SYSTEM Instructions for the Experienced MiniMed 630G System User USING THE MINIMED 670G SYSTEM: INSTRUCTIONS FOR THE EXPERIENCED USER Checklist for starting on your MiniMed 670G
More informationVIRTUAL PATIENTS DERIVED FROM THE
VIRTUAL PATIENTS DERIVED FROM THE CARELINK DATABASE Benyamin Grosman PhD Senior Principle Scientist Medtronic Diabetes WHY VIRTUAL PATIENT MODELING? Reduce the cost of clinical trials Use models in conjunction
More informationRELEASED. Clearing your active insulin
To clear all your settings: 1. Make sure the pump is not connected to your body. 2. Go to the Manage Settings screen. Menu > Utilities > Manage Settings 3. Simultaneously press and hold and until the Manage
More informationTHERAPY MANAGEMENT SOFTWARE FOR DIABETES
THERAPY MANAGEMENT SOFTWARE FOR DIABETES Report Report Interpretation Reference Guide Guide 2009 Medtronic MiniMed. All rights reserved. 6025274-012_a CareLink Pro Report Reference Guide 0 p.2 Adherence
More informationTHERAPY MANAGEMENT SOFTWARE FOR DIABETES
THERAPY MANAGEMENT SOFTWARE FOR DIABETES Report Report Interpretation Reference Guide Guide 2007 Medtronic MiniMed. All rights reserved. 6025274-0U2 120707 CareLink Pro Report Reference Guide 0 p.2 Sensor
More informationWelcome to CareLink Pro
Reference Guide Welcome to CareLink Pro This guide was developed to serve as a reference for obtaining patient data and reviewing CareLink Pro reports. Getting Started with CareLink Pro Adding New Patients
More informationPATIENT TRAINING CHECKLIST MINIMED 670G SYSTEM
Technical Training Insulin Pump Infusion Set: Insulin Pump Model: BASIC FEATURES Patient has demonstrated understanding of: Button Functions Home Screen Menu review Status Screens Battery type/insertion
More informationScience Behind Insulin Delivery
Science Behind Insulin Delivery 1 Overview Objective The objective of this presentation is to demonstrate why insulin pump therapy is more effective than multiple daily shots in delivering superior outcomes
More informationUnderstanding the CareLink TM Therapy Management Dashboard Report
3 2 1 5 6 7 4 1 This is a great place to start recognizing trends. In this example you may see plenty of events that result in a low glucose trend. A low glucose is identified as a value less than 70mg/dL.
More informationGetting Started. Learning Guide. with Insulin Pump Therapy. PUMP Foundations. for the MiniMed 530G with Enlite
Getting Started with Insulin Pump Therapy for the MiniMed 530G with Enlite Learning Guide PUMP Foundations MiniMed 530G Insulin Pump Settings Form: We recommend that you record all settings on this form
More informationUnderstanding the CareLinkTM Sensor Meter Overview Report: Page 1
Understanding the CareLinkTM Sensor Meter Overview Report: Page 1 Sensor & Meter Overview (1 of 3) 4-Hour Glucose Sensor Overlay - Readings & Averages (mg/dl) 1 Glucose Sensor Overlay Bedtime to Wake-Up
More informationUsing the Bolus Wizard Calculator
9501179-011 Using the Bolus Wizard Calculator Objective Describe the features and benefits of the Bolus Wizard Calculator Key Points The Bolus Wizard: Estimates high blood glucose corrections using the
More informationCARELINK PERSONAL ACTIONABLE INSIGHTS FOR BETTER DIABETES MANAGEMENT CARELINK REPORTS GUIDE
CARELINK PERSONAL ACTIONABLE INSIGHTS FOR BETTER DIABETES MANAGEMENT CARELINK REPORTS GUIDE CARELINK PERSONAL ACTIONABLE INSIGHTS FOR BETTER DIABETES MANAGEMENT As part of your diabetes therapy you have
More information1. Continuous Glucose Monitoring
1. Continuous Glucose Monitoring 1. Physiology of interstitial fluid glucose 2. Comparison of CGM and self-monitored blood glucose (SMBG) data 3. Insulin dosing indication in BGM vs. CGM & the FDA 4. Protection
More informationMINIMED 640G WITH SMARTGUARD GIVES YOU CONFIDENCE TO TAKE CONTROL OF YOUR DIABETES
MINIMED 640G WITH SMARTGUARD GIVES YOU CONFIDENCE OF YOUR DIABETES HAVE YOU CONSIDERED THE REAL IMPACT HYPOS HAVE ON YOUR LIFE? AN ESTIMATED 1 HOUR EVERY DAY IS LOST TO THE MANAGEMENT OF 43% OF PEOPLE
More informationInsulin Pumps and Continuous Glucose Sensors- Embracing Technology. Susan Cavalier, BS, RN, CDE Manager, Diabetes Educator Sanford Diabetes Education
Insulin Pumps and Continuous Glucose Sensors- Embracing Technology Susan Cavalier, BS, RN, CDE Manager, Diabetes Educator Sanford Diabetes Education Diabetes Management Tools in 1974 Insulin pump history
More informationUNDERSTANDING THE BASIC FEATURES AND MANAGEMENT IN THE SCHOOL SETTING CHRISTINE HERTLER RN BSN CDE & MARY MCCARTHY RN CDE
UNDERSTANDING THE BASIC FEATURES AND MANAGEMENT IN THE SCHOOL SETTING CHRISTINE HERTLER RN BSN CDE & MARY MCCARTHY RN CDE The insulin pump Replaces injections Delivers insulin through a soft cannula
More informationUnderstanding the Assessment and Progress Report
Understanding the ssessment and Progress Report ssessment and Progress 8//2-8/7/2 (7 Days) 3 7/2/2-7/27/2 (7 Days) 4 25-75% -% verage 2 4: M- 5:4 M Hyperglycemic patterns() :45 PM- :3 PM 2 3 :2 M- :5 M
More informationWOULD YOU LIKE MORE CONFIDENCE IN YOUR HYPOGLYCAEMIC CONTROL? SMARTGUARD. PROVIDES PREDICTIVE PROTECTION
WOULD YOU LIKE MORE CONFIDENCE IN YOUR HYPOGLYCAEMIC CONTROL? SMARTGUARD. PROVIDES PREDICTIVE PROTECTION 1,2 MINIMED 640G WITH SMARTGUARD HAVE YOU CONSIDERED THE REAL IMPACT HYPOGLYCAEMIA HAS ON YOUR LIFE?
More informationFine-tuning of The Dose of Insulin Pump
Fine-tuning of The Dose of Insulin Pump The manual does not guarantee specific individual or specific applicability of the environment, there is no express or implied warranties. Contents of this manual
More informationWOULD YOU LIKE TO REDUCE THE FEAR OF HYPOGLYCAEMIA FOR YOUR PATIENTS?
WOULD YOU LIKE TO REDUCE THE FEAR OF HYPOGLYCAEMIA FOR YOUR PATIENTS? THE ONLY SYSTEM CLINICALLY PROVEN TO REDUCE HYPOGLYCAEMIA MINIMED 640G SYSTEM WITH SMARTGUARD TECHNOLOGY 1 HYPOGLYCAEMIA IS CHALLENGING
More informationHow to Transfer Your Settings
How to Transfer Your Settings for your Replacement MiniMed 530G System Let s get started! Step 1: Before you send your original pump back, copy your current settings onto the Insulin Pump Settings Form.
More informationREPORT INTERPRETATION
REPORT INTERPRETATION: Interpreting ipro Professional Continuous Glucose Monitoring (CGM) Reports and Making Therapy Adjustments TARGET AUDIENCE The audience for this section is physicians, mid-level practitioners,
More informationLive life, less complicated. InPen MOBILE APP. Healthcare Provider INSTRUCTIONS FOR USE. CompanionMedical.com
InPen MOBILE APP Healthcare Provider INSTRUCTIONS FOR USE TABLE OF CONTENTS Introduction...3 InPen Mobile App...3 Intended Use...3 Indications for Use...3 Contraindications...3 Start Orders...4 General
More informationAdvances in Technology in the Treatment of Diabetes Mellitus 2017 How far have we come-how far are we going? Is there a final frontier?
Advances in Technology in the Treatment of Diabetes Mellitus 2017 How far have we come-how far are we going? Is there a final frontier? Alan B Schorr DO FAAIM FACE www.sugardoc.com abs@sugardoc.com Disclosures
More informationDiabetes Management: Current High Tech Innovations
Diabetes Management: Current High Tech Innovations How Far We ve Come in the Last 40 Years William V. Tamborlane, MD Department of Pediatrics Yale School of Medicine Disclosures I am a consultant for:
More informationDiabetes Technology Update. Sarah Konigsberg, MD Diabetes & Endocrine Assoc. April 7, 2018
Diabetes Technology Update Sarah Konigsberg, MD Diabetes & Endocrine Assoc. April 7, 2018 Disclosures None No future technologies are FDA approved Continuous Glucose Monitors Continuous Glucose Monitors
More informationTHE ONLY SYSTEM^ CLINICALLY PROVEN TO REDUCE HYPOGLYCAEMIA
THE ONLY SYSTEM^ CLINICALLY PROVEN TO REDUCE HYPOGLYCAEMIA MINIMED 640G system^ with SmartGuard technology HYPOGLYCAEMIA IS CHALLENGING FOR GLYCAEMIC CONTROL 1 AND quality of life 2 Achieving good glucose
More informationEmerging Automated Insulin Delivery Systems
Emerging Automated Insulin Delivery Systems Richard M. Bergenstal, MD International Diabetes Center Park Nicollet & HealthPartners Minneapolis, MN Presenter Name 1 Dualities: Richard M. Bergenstal, MD
More informationThe Realities of Technology in Type 1 Diabetes
The Realities of Technology in Type 1 Diabetes May 6, 2017 Rosanna Fiallo-scharer, MD Margaret Frederick, RN Disclosures I have no conflicts of interest to disclose I will discuss some unapproved treatments
More informationGETTING STARTED WITH CONTINUOUS GLUCOSE MONITORING
GETTING STARTED WITH CONTINUOUS GLUCOSE MONITORING TABLE OF CONTENTS GETTING STARTED WITH CONTINUOUS GLUCOSE MONITORING SECTION 1: Introduction to Continuous Glucose Monitoring... 3 SECTION 2: Sensor Glucose
More informationDiabetes and Technology. Saturday, September 9, 2017 Aimee G sell, APRN, ANP-C, CDE
Diabetes and Technology Saturday, September 9, 2017 Aimee G sell, APRN, ANP-C, CDE Disclosure Speaker s Bureau: Janssan Pharmaceuticals Current Technology V-Go by Valeritas Continuous Sensors (personal
More informationTechnology for Diabetes: 101 Basic Rules of the Road. Karen Hamon RN, BSN, CDE Stephen Stone MD, FAAP Neil H. White, MD, CDE
Technology for Diabetes: 101 Basic Rules of the Road Karen Hamon RN, BSN, CDE Stephen Stone MD, FAAP Neil H. White, MD, CDE Quick Pump Facts! o Constant insulin supply o Pager-sized mini-computer worn
More informationPredicts and helps prevent lows with. zero fingersticks NOW FEATURING BASAL-IQ TECHNOLOGY
Predicts and helps prevent lows with * zero fingersticks NOW FEATURING BASAL-IQ TECHNOLOGY Basal-IQ Technology is not a substitute for active self-management of your diabetes. Please see back cover for
More informationBlood glucose Meter Roche USA V6/ PMS 287 Proof Print Number 209 Advanced Owner s Booklet
This file may not print or view at 100%. Die lines and color breaks do not print. Roche USA 50841 V6/1 06434258002 Black Proof Print Number 209 06434258002-0512 Roche USA 50841 V6/2 06434258002 Cyan Proof
More informationCGM: Continuous Glucose Monitoring Making Sense of It All AW: ANCO/GEND/1016/0117
CGM: Continuous Glucose Monitoring Making Sense of It All Objectives Review how to do a time effective interpretation of CGM and insulin pump download data Review how medications, lifestyle, and current
More informationPeople with type 1 diabetes and Do It Yourself (DIY) technology solutions ABOUT THIS POSITION STATEMENT
Position Statement People with type 1 diabetes and Do It Yourself (DIY) technology solutions ABOUT THIS POSITION STATEMENT Diabetes Australia believes that people with diabetes should have choice and access
More informationObjectives. The Problem. We ve come a LONG way, Innovations in Diabetes Care and Management. Barbara Walz, RN, BSN, CDE April 26, 2018
Objectives Innovations in Diabetes Care and Management Barbara Walz, RN, BSN, CDE April 26, 2018 1. Briefly discuss the history of diabetes management over the past 100 years 2. Describe the impact of
More informationWHAT CAN I DO TO REDUCE MY RISK OF DEVELOPING THE COMPLICATIONS OF TYPE 1 DIABETES?
Christian In better control with his pump since 2012 WHAT CAN I DO TO REDUCE MY RISK OF DEVELOPING THE COMPLICATIONS OF TYPE 1 DIABETES? Many people with Type 1 diabetes worry about potential long-term
More informationPresented by Dr. Bruce Perkins, MD MPH Dr. Michael Riddell, PhD
Type 1 Diabetes and Exercise: Optimizing the Medtronic MiniMed Veo Insulin Pump and Continuous Glucose Monitoring (CGM) for Better Glucose Control 1,2 for Healthcare Professionals Presented by Dr. Bruce
More informationDISCOVER THE POWER OF CONNECTION MINIMED 640G
DISCOVER THE POWER OF CONNECTION MINIMED 640G INSULIN PUMP THERAPY CHANGING LIVES TODAY Has your child just been diagnosed with insulin dependent diabetes? Or perhaps they ve been on multiple daily injection
More informationDiabetes Medical Management Plan (DMMP)
Diabetes Medical Management Plan (DMMP) This plan should be completed by the student s personal diabetes health care team, including the parents/guardians. It should be reviewed with relevant school staff
More informationBREAKDOWN OF THE CARELINK REPORTS GETTING STARTED WITH CARELINK PERSONAL SOFTWARE
BREAKDOWN OF THE CARELINK REPORTS GETTING STARTED WITH CARELINK PERSONAL SOFTWARE TABLE OF CONTENTS GETTING STARTED WITH CARELINK PERSONAL SOFTWARE Introducing CareLink Personal Software Before You Start...
More informationGETTING STARTED WITH MINIMED 670G CONTINUOUS GLUCOSE MONITORING
GETTING STARTED WITH MINIMED 670G CONTINUOUS GLUCOSE MONITORING Contents Continuous Glucose Monitoring Getting started with continuous glucose monitoring Section 1: Section 2: Section 3: Section 4: Section
More informationInterpreting the charts & graphs
Report reference guide mg/dl The diasend solution Interpreting the charts & graphs diasend is a universal cloud-based diabetes data management system, that enables you to upload data from meters, pumps
More informationDate of birth: Type 2 Other: Parent/guardian 1: Address: Telephone: Home: Work: Cell: address: Camper physician / health care provider:
Day & Evening Camp 2018 Specialized Health Care Diabetes Medical Management Plan Must be completed if your camper has diabetes. Parent/guardian and physician signature required. **We will also accept copies
More informationMORE TIME TO BE. The MiniMed 670G system. Less time thinking about managing your diabetes. *1 More time focusing on your day. 2,3
MORE TIME TO BE Leanne. MiniMed TM 670G Ambassador The MiniMed 670G system Less time thinking about managing your diabetes. *1 More time focusing on your day. 2,3 *Some user interaction required. THE SYSTEM
More informationInsulin Pump Therapy in children. Prof. Abdulmoein Al-Agha, FRCPCH(UK)
Insulin Pump Therapy in children Prof. Abdulmoein Al-Agha, FRCPCH(UK) aagha@kau.edu.sa Highlights Evolution of insulin pump Pumps mimics Pancreas Goals of diabetes care What lowers HbA1c Criteria for selection
More informationDiabetes II Insulin pumps; Continuous glucose monitoring system (CGMS) Ernest Asamoah, MD FACE FACP FRCP (Lond)
Diabetes II Insulin pumps; Continuous glucose monitoring system (CGMS) Ernest Asamoah, MD FACE FACP FRCP (Lond) 9501366-011 20110401 Objectives Understand the need for insulin pumps and CGMS in managing
More informationHow to Transfer Your Settings
How to Transfer Your Settings for your Replacement Paradigm REAL-Time Revel Insulin Pump Let s get started! Step 1: Before you send your original pump back, copy your current settings onto the Insulin
More informationIntroducing DEXCOM STUDIO INTUITIVE. FOCUSED. SIMPLIFIED. HELP TAKE the GUESSWORK OUT of GLUCOSE PATTERN MANAGEMENT
DEXCOM STUDIO Introducing Continuous Glucose Monitoring Software INTUITIVE. FOCUSED. SIMPLIFIED. HELP TAKE the GUESSWORK OUT of GLUCOSE PATTERN MANAGEMENT GLUCOSE PATTERN MANAGEMENT Pre and Post Prandial
More informationDiabetes Medical Management Plan (DMMP)
Diabetes Medical Management Plan (DMMP) Page 1 of 7, DMMP This plan should be completed by the student s personal diabetes health care team, including the parents/guardians. It should be reviewed with
More informationCGM Therapy Expert Program
CGM Therapy Expert Program PROGRAM OVERVIEW The Medtronic-Bayer CGM Therapy Expert Program is designed to update healthcare professionals on the most current scientific and technical information regarding
More informationVirginia Diabetes Medical Management Plan (DMMP)
Virginia Diabetes Medical Management Plan (DMMP) Adapted from the National Diabetes Education Program DMMP (2016) This plan should be completed by the student s personal diabetes health care team, including
More informationWhat is the role of insulin pumps in the modern day care of patients with Type 1 diabetes?
What is the role of insulin pumps in the modern day care of patients with Type 1 diabetes? Dr. Fiona Wotherspoon Consultant in Diabetes and Endocrinology Dorset County Hospital Fiona.Wotherspoon@dchft.nhs.uk
More informationGetting you up to speed Quick Reference Guide
Getting you up to speed Quick Reference Guide 1. Important Information This Quick Reference Guide provides a snapshot of the key features of your Animas Vibe Insulin Pump and Dexcom G4 CGM Sensor and Transmitter
More informationReport reference guide. mmol/l. One. solution EMR. No fuss
Report reference guide mmol/l One solution No fuss 0000000000 00 0 0000 00 0 0 0 0 0 0 000000000 0 0 00 0 0 0 00 00 0 0 0 0 0 0 00 00000000000000000000 00 EMR About diasend. Plug Transmitter into your
More informationMaking the Most of Continuous Glucose Monitoring
Making the Most of Continuous Glucose Monitoring Gary Scheiner MS, CDE Owner & Clinical Director Integrated Diabetes Services LLC Wynnewood, PA AADE 2014 Diabetes Educator of the Year gary@integrateddiabetes.com
More information7/18/2017. Everything discussed in this presentation is off-label. (And that s ok.) Dana Lewis Founder, #OpenAPS WARNING: Disclosure to Participants
Dana Lewis Founder, #OpenAPS Seattle, WA Disclosure to Participants Notice of Requirements For Successful Completion Please refer to learning goals and objectives Learners must attend the full activity
More informationCurrent Glucometers. Junior s s Glucose Log. All have advantages and disadvantages Answer 2
Diabetes Dilemmas: Using Technology To Solve Clinical Conundrums Stephen E. Gitelman, MD UCSF A teenager with type 1 diabetes for 5 years comes into your office for a follow- up visit. You want to review
More informationGetting Started. with Continuous Glucose Monitoring. Learning Guide
Getting Started with Continuous Glucose Monitoring Learning Guide Getting Started with Continuous Glucose Monitoring Keys to Success Getting Started with CGM: Learning Guide TRENDS CGM finally lets you
More informationDiabetes Medical Management Plan (DMMP) Adapted from Helping the Student with Diabetes Succeed: A Guide for School Personnel (2016)
Diabetes Medical Management Plan (DMMP) Adapted from Helping the Student with Diabetes Succeed: A Guide for School Personnel (2016) This plan should be completed by the student's personal diabetes health
More informationNow you know. InPen MOBILE APP. Healthcare Provider INSTRUCTIONS FOR USE. CompanionMedical.com Companion Medical, Inc.
InPen MOBILE APP Healthcare Provider INSTRUCTIONS FOR USE 2017 Companion Medical, Inc. LBL-00235-AC TABLE OF CONTENTS Introduction...3 InPen Mobile App...3 Intended Use...3 Indications for Use...3 Contraindications...3
More informationMINIMED 640G SYSTEM^ Getting Started WITH CONTINUOUS GLUCOSE MONITORING
MINIMED 640G SYSTEM^ Getting Started WITH CONTINUOUS GLUCOSE MONITORING let s get started! Table of Contents Section 1: Continuous Glucose Monitoring System Components... 2 Section 2: Sensor Glucose (SG)
More informationDURING TRAINING CONTINUOUS GLUCOSE MONITORING MINIMED 630G SYSTEM
DURING TRAINING CONTINUOUS GLUCOSE MONITORING MINIMED 630G SYSTEM TABLE OF CONTENTS DURING TRAINING CONTINUOUS GLUCOSE MONITORING MINIMED 630G SYSTEM Welcome... Section 1: Getting Started... Section :
More informationNext steps for success.
Next steps for success. More tips for using CGM* training course. The Animas Vibe System is approved for persons age 2 and older. *Continuous Glucose Monitoring Important Safety Information The Animas
More informationInsulin Pump Therapy. WakeMed Children s Endocrinology & Diabetes WakeMed Health & Hospitals Version 1.3, rev 5/21/13 MP
Insulin Pump Therapy WakeMed Children s Endocrinology & Diabetes Overview What is an insulin pump? What are the advantages and disadvantages of an insulin pump? Lifestyle Changes Food Management Exercise
More informationINSULIN INITIATION AND INTENSIFICATION WITH A FOCUS ON HYPOGLYCEMIA REDUCTION
INSULIN INITIATION AND INTENSIFICATION WITH A FOCUS ON HYPOGLYCEMIA REDUCTION Jaiwant Rangi, MD, FACE Nov 10 th 2018 DISCLOSURES Speaker Novo Nordisk Sanofi-Aventis Boheringer Ingleheim Merck Abbvie Abbott
More informationReal-Time Continuous Glucose Monitoring: From Application to Evaluation
Real-Time Continuous Glucose Monitoring: From Application to Evaluation Gary Scheiner MS, CDE Owner/Director, Integrated Diabetes Services 333 E. Lancaster Ave., Suite 24 Wynnewood, PA 1996 (877) 735-3648
More informationDiabetes Medical Management Plan (DMMP)
Diabetes Medical Management Plan (DMMP) This plan should be completed by the student s personal diabetes health care team, including the parents/guardian. It should be reviewed with relevant school staff
More informationThe Growing Future of Diabetes: Insulin Pump Therapy in Type 1 and 2 Diabetes
The Growing Future of Diabetes: Insulin Pump Therapy in Type 1 and 2 Diabetes Sarah Dombrowski, PharmD, BCACP Pennsylvania Pharmacists Association 10/20/18 1 Objectives At the completion of this activity,
More informationAnneli, Martina s daughter In better control with her pump since 2011 MY CHILD HAS TYPE 1 DIABETES
Anneli, Martina s daughter In better control with her pump since 2011 MY CHILD HAS TYPE 1 DIABETES Many parents whose child is diagnosed with Type 1 diabetes wonder: Why is this happening to my child?
More informationGLOOKO REPORT REFERENCE GUIDE
GLOOKO REPORT REFERENCE GUIDE November 2018 Version IFU-0010 02 Contents Intended Use... 2 Warnings... 2 Introduction... 3 Reports... 4 Report Criteria...4 Date Range... 4 Glucose Data Source... 4 Exercise
More informationParadigm/Guardian CGM Screens. CareLink Online Reports. Make Your Own Jackson Pollack. CGM by Jackson Pollack. How To Read CGM Screens/Reports
CGM by Jackson Pollack One Pollack sold for $140 million in 1996! Make Your Own Jackson Pollack How To Read CGM Screens/Reports For only $1,000! Paradigm/Guardian CGM Screens On-Screen Reports 3 / 6 /
More informationMedtronic MiniMed Insulin Infusion Pumps
Medtronic MiniMed Insulin Infusion Pumps Patients should always discuss potential risks and benefits with a physician. Please review the product manual prior to use for detailed instructions and disclosure.
More informationAuthorization for MAT Diabetes Certified Staff to Administer Insulin and/or Glucagon
Medication Administration Training for Child Day Programs Handout B.1 Authorization for MAT Diabetes Certified Staff to Administer Insulin and/or Glucagon Child s Name: Child s Date of Birth: Child Day
More informationMEDICAL POLICY Continuous Glucose Monitoring Systems and Insulin Pumps
POLICY: PG0177 ORIGINAL EFFECTIVE: 12/01/08 LAST REVIEW: 02/13/18 MEDICAL POLICY Continuous Glucose Monitoring Systems and Insulin Pumps GUIDELINES This policy does not certify benefits or authorization
More informationAmbulatory Artificial Pancreas Platform (AAPP) User Manual
Ambulatory Artificial Pancreas Platform (AAPP) User Manual Welcome to the Artificial Pancreas User Manual. This manual is intended to teach you how to use the system in your clinical trial. If questions
More informationContinuous Glucose Monitoring
Continuous Glucose Monitoring Information about fully-subsidised continuous glucose monitoring for children and young people with type 1 diabetes Continuous glucose monitoring (CGM) can help in managing
More informationAbbott FreeStyle Libre Pro System
, the Professional CGM Abbott FreeStyle Libre Pro Reader Kit includes: Reader, USB cable, interactive tutorial on USB, and power adapter, user s manual, Quick Start Guide, Quick Reference Guide Kit includes:
More informationDiabetes Medical Management Plan (DMMP) Handout C.1
This plan should be completed by the child s personal diabetes health care team, including the parents/guardian. It should be reviewed with relevant program staff and copies should be kept in a place that
More informationAviva Combo BLOOD GLUCOSE METER. Advanced Owner s Booklet for Self-Testing Only
Aviva Combo BLOOD GLUCOSE METER Advanced Owner s Booklet for Self-Testing Only Before You Start Testing About the meter and test strips Carefully read and follow the instructions in the Getting Started
More informationGETTING STARTED. Continuous Glucose Monitoring MiniMed 630G System
GETTING STARTED Continuous Glucose Monitoring MiniMed 630G System WARNING: Do not use the Suspend on low feature until you have read the information in this Getting Started Guide and received instructions
More informationDiabetes Medical Management Plan (DMMP)
Diabetes Medical Management Plan (DMMP) This plan should be completed by the camper s personal diabetes health care team, including the parents/guardian. It should be reviewed with relevant staff and copies
More informationFirst steps for success.
First steps for success. Getting to know continuous glucose monitoring (CGM). The Animas Vibe System is approved for persons age 2 and older. Important Safety Information The Animas Vibe Insulin Pump and
More information10:20 AM March 5, B 100% 235 u. 124 mg/dl 3 HRS INSULIN ON BOARD:
DEXCOM G5 MOBILE CGM COMPATIBLE B 100% 235 u INSULIN ON BOARD: OPTIONS 10:20 AM March 5, 2017 400 350 300 250 200 150 100 50 1.1 u 1:09 hrs BOLUS 124 mg/dl 3 HRS The pump that gets updated, not outdated.
More informationDISCOVER THE POWER OF CONNECTION MINIMED 640G
DISCOVER THE POWER OF CONNECTION MINIMED 640G INSULIN PUMP THERAPY CHANGING LIVES TODAY Have you just been diagnosed with insulin dependent diabetes? Perhaps you ve been on multiple daily injection therapy
More informationUvA-DARE (Digital Academic Repository) The artificial pancreas Kropff, J. Link to publication
UvA-DARE (Digital Academic Repository) The artificial pancreas Kropff, J. Link to publication Citation for published version (APA): Kropff, J. (2017). The artificial pancreas: From logic to life General
More informationCANDY Camp Application
CANDY Camp Application Please complete the following form and submit it by June 15, 2016. Please mail form to Bonnie Kruse, Diabetes Program Coordinator, HSHS St. Anthony s Memorial Hospital, 503 North
More information